tiprankstipranks
Trending News
More News >

Vaccinex Delays Yearly Report Filing

Story Highlights

Vaccinex ( (VCNX) ) has released a notification of late filing.

Vaccinex, Inc., a biotechnology company, has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for the delay is the company’s difficulty in completing its financial statements for the year, which could not be resolved without unreasonable effort or expense. Vaccinex expects to file the report within the 15-day extension period allowed under Rule 12b-25. The company does not anticipate any significant changes in its financial results compared to the previous fiscal year. Vaccinex remains committed to compliance and has ensured all other required reports have been filed. The notification was signed by Jill Sanchez, the Chief Financial Officer.

More about Vaccinex

YTD Price Performance: -19.89%

Average Trading Volume: 4,525

Technical Sentiment Signal: Buy

Current Market Cap: $1.95M

Find detailed analytics on VCNX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App